Chlorine in PDB 8fa0: Crystal Structure of Clade A/E 93TH057 Hiv-1 GP120 Core in Complex with Nbd-14208, An Hiv-1 GP120 Antagonist

Protein crystallography data

The structure of Crystal Structure of Clade A/E 93TH057 Hiv-1 GP120 Core in Complex with Nbd-14208, An Hiv-1 GP120 Antagonist, PDB code: 8fa0 was solved by Y.D.Kwon, P.D.Kwong, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 36.35 / 2.09
Space group P 21 21 21
Cell size a, b, c (Å), α, β, γ (°) 61.213, 66.97, 90.351, 90, 90, 90
R / Rfree (%) 24.3 / 29.8

Other elements in 8fa0:

The structure of Crystal Structure of Clade A/E 93TH057 Hiv-1 GP120 Core in Complex with Nbd-14208, An Hiv-1 GP120 Antagonist also contains other interesting chemical elements:

Fluorine (F) 4 atoms

Chlorine Binding Sites:

The binding sites of Chlorine atom in the Crystal Structure of Clade A/E 93TH057 Hiv-1 GP120 Core in Complex with Nbd-14208, An Hiv-1 GP120 Antagonist (pdb code 8fa0). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total 2 binding sites of Chlorine where determined in the Crystal Structure of Clade A/E 93TH057 Hiv-1 GP120 Core in Complex with Nbd-14208, An Hiv-1 GP120 Antagonist, PDB code: 8fa0:
Jump to Chlorine binding site number: 1; 2;

Chlorine binding site 1 out of 2 in 8fa0

Go back to Chlorine Binding Sites List in 8fa0
Chlorine binding site 1 out of 2 in the Crystal Structure of Clade A/E 93TH057 Hiv-1 GP120 Core in Complex with Nbd-14208, An Hiv-1 GP120 Antagonist


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Crystal Structure of Clade A/E 93TH057 Hiv-1 GP120 Core in Complex with Nbd-14208, An Hiv-1 GP120 Antagonist within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl509

b:82.4
occ:1.00
CL17 A:XKR509 0.0 82.4 1.0
C16 A:XKR509 1.7 74.4 1.0
C14 A:XKR509 2.7 72.8 1.0
C18 A:XKR509 2.7 71.0 1.0
F19 A:XKR509 2.9 69.8 1.0
F15 A:XKR509 2.9 71.4 1.0
CA A:PHE376 3.4 44.5 1.0
N A:PHE376 3.5 44.5 1.0
C A:PHE376 3.7 46.4 1.0
C A:SER375 3.9 46.9 1.0
C13 A:XKR509 4.0 70.8 1.0
C20 A:XKR509 4.0 70.1 1.0
O A:PHE376 4.1 45.6 1.0
CD2 A:PHE382 4.1 46.5 1.0
O A:VAL255 4.1 48.4 1.0
O A:SER375 4.2 44.8 1.0
N A:ASN377 4.2 45.6 1.0
CB A:SER375 4.3 60.7 1.0
CE2 A:PHE382 4.3 47.8 1.0
CG1 A:VAL255 4.6 47.9 1.0
C12 A:XKR509 4.6 68.4 1.0
OG A:SER375 4.7 69.9 1.0
H201 A:XKR509 4.7 84.2 1.0
H131 A:XKR509 4.7 85.0 1.0
CH2 A:TRP112 4.7 45.9 1.0
CA A:SER375 4.7 51.0 1.0
C A:VAL255 4.7 46.3 1.0
CB A:PHE376 4.8 44.3 1.0

Chlorine binding site 2 out of 2 in 8fa0

Go back to Chlorine Binding Sites List in 8fa0
Chlorine binding site 2 out of 2 in the Crystal Structure of Clade A/E 93TH057 Hiv-1 GP120 Core in Complex with Nbd-14208, An Hiv-1 GP120 Antagonist


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 2 of Crystal Structure of Clade A/E 93TH057 Hiv-1 GP120 Core in Complex with Nbd-14208, An Hiv-1 GP120 Antagonist within 5.0Å range:
probe atom residue distance (Å) B Occ
A:Cl510

b:56.0
occ:1.00
CL17 A:XKR510 0.0 56.0 1.0
C16 A:XKR510 1.7 57.1 1.0
C18 A:XKR510 2.7 57.2 1.0
C14 A:XKR510 2.8 57.3 1.0
F19 A:XKR510 2.9 58.7 1.0
F15 A:XKR510 3.0 57.9 1.0
SD A:MET434 3.5 78.2 1.0
CB A:VAL120 3.7 63.4 1.0
CG2 A:VAL120 3.7 62.7 1.0
CG1 A:VAL120 3.8 65.4 1.0
CB A:MET434 3.9 64.7 1.0
C13 A:XKR510 4.1 57.6 1.0
C20 A:XKR510 4.1 58.1 1.0
CG A:MET434 4.1 69.8 1.0
CE A:MET434 4.3 81.2 1.0
C12 A:XKR510 4.7 58.6 1.0
H131 A:XKR510 4.7 69.1 1.0
H201 A:XKR510 4.7 69.7 1.0
O A:HOH601 4.8 76.6 1.0

Reference:

F.Curreli, Y.D.Kwon, I.Nicolau, G.Burgos, A.Altieri, A.V.Kurkin, R.Verardi, P.D.Kwong, A.K.Debnath. Antiviral Activity and Crystal Structures of Hiv-1 GP120 Antagonists. Int J Mol Sci V. 23 2022.
ISSN: ESSN 1422-0067
PubMed: 36555641
DOI: 10.3390/IJMS232415999
Page generated: Tue Apr 4 22:55:06 2023

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy